Northern Arc has secured USD 65 million for its first climate fund, aiming to support sustainable businesses in India. The fund, backed by DFC and OeEB, will provide debt financing to companies in renewable energy, energy efficiency, and other green sectors.
Posts in category All News
TARSONS products ltd (07-11-2024)
Today Tarsons Posted Result. Looks like turnaround is happening. Standalone revenue grew yoy.margin uptick QOQ
Consolidated basis EBITDA is increasing and more than Standalone EBITDA. Consolidated PBT is still below Standalone PBT.
First time studying the co. looks interesting. Anybody can share their interpretation?
Might be we are looking at when things turn good maybe.
Emcure Pharma Q2 Results: Net profit rises 38% to Rs 202 crore, revenue jumps 20% (07-11-2024)
Emcure Pharmaceuticals reported a 38.2% YoY rise in Q2FY25 net profit to Rs 202 crore, driven by strong domestic and international sales. Revenues grew 20.4% to Rs 2,002 crore, while EBITDA rose 26%, with margins at 20.8%.
JB Pharma Q2 Results: Net profit jumps 16% to Rs 175 crore, revenue up 13% (07-11-2024)
JB Pharma reported a 16% YoY increase in Q2FY25 net profit to Rs 175 crore, driven by 22% growth in domestic business. Revenues rose 13% to Rs 1,001 crore, while EBITDA grew 13%, maintaining margins at 28.4%.
Arman Financial Services Ltd (07-11-2024)
I believe Arman will be among first few to take benefit when the cycle will turn around. another good company is Muthoot Microfinance in this sector.
Alembic Pharma Q2 Results: Net profit rises 12% to Rs 153 crore, revenue up 3% (07-11-2024)
Alembic Pharma reported a 12% YoY rise in Q2FY25 net profit to Rs 153 crore, driven by strong domestic and US market sales. Revenues grew 3% to Rs 1648 crore, while EBITDA declined 6%, with margins at 15.6%
Sustained AUM growth, firm asset quality bode well for Aadhar Housing Finance (07-11-2024)
Aadhar Housing Finance’s stock has risen 47% since its IPO, driven by strong growth and government focus on affordable housing. Despite market volatility, the stock has gained 8% in the past month, attracting investor interest.
NCC: Extremely undervalued (07-11-2024)
Execution is impacted in Monsoons typically. H1 has had a double whammy for a lot of EPCs – elections, then Monsoons.
Microcap momentum portfolio (07-11-2024)
I checked in Care Reports where FY24 revenue is 200 odd Crore while PAT has dropped to negative which was approx 22cr in FY23. Is it correct?
Where can I find the latest numbers?
Also please share your rationale behind 450cr number. Will be helpful. Thanks in advance.
